1285 related articles for article (PubMed ID: 22503066)
21. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.
Lawindy SM; Kurian T; Kim T; Mangar D; Armstrong PA; Alsina AE; Sheffield C; Sexton WJ; Spiess PE
BJU Int; 2012 Oct; 110(7):926-39. PubMed ID: 22540179
[TBL] [Abstract][Full Text] [Related]
22. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
23. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy.
Vasudevan A; Davies RJ; Shannon BA; Cohen RJ
BJU Int; 2006 May; 97(5):946-9. PubMed ID: 16643475
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
[TBL] [Abstract][Full Text] [Related]
25. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
26. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
27. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
[TBL] [Abstract][Full Text] [Related]
28. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
29. The current role of percutaneous needle biopsies of renal tumours.
Volpe A; Terrone C; Scarpa RM
Arch Ital Urol Androl; 2009 Jun; 81(2):107-12. PubMed ID: 19760866
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of percutaneous biopsy of the renal masses. 73 cases].
Daniel L; Barriol D; Lechevallier E; André M; De Fromont M; Charafe E; Coulange C; Pellissier J
Ann Pathol; 2000 Mar; 20(2):119-23. PubMed ID: 10740006
[TBL] [Abstract][Full Text] [Related]
32. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up.
Somani BK; Nabi G; Thorpe P; N'Dow J; Swami S; McClinton S;
Eur Urol; 2007 May; 51(5):1289-95; discussion 1296-7. PubMed ID: 17081679
[TBL] [Abstract][Full Text] [Related]
33. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
[TBL] [Abstract][Full Text] [Related]
34. Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
Simhan J; Canter DJ; Sterious SN; Smaldone MC; Tsai KJ; Li T; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Uzzo RG
J Urol; 2013 Jan; 189(1):43-7. PubMed ID: 23164383
[TBL] [Abstract][Full Text] [Related]
35. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
36. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
37. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
38. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
[TBL] [Abstract][Full Text] [Related]
39. Fine-needle percutaneous biopsy of renal masses with helical CT guidance.
Lechevallier E; André M; Barriol D; Daniel L; Eghazarian C; De Fromont M; Rossi D; Coulange C
Radiology; 2000 Aug; 216(2):506-10. PubMed ID: 10924578
[TBL] [Abstract][Full Text] [Related]
40. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
